Various Techniques for the Surgical Treatment of Common Bile Duct Stones: A Meta Review
Hindawi Publishing Corporation
Gastroenterology Research and Practice
Volume 2009, Article ID 840208, 12 pages
doi:10.1155/2009/840208
Review Article
Various Techniques for the Surgical Treatment of Common Bile
Duct Stones: A Meta Review
Abolfazl Shojaiefard,1 Majid Esmaeilzadeh,2 Ali Ghafouri,1 and Arianeb Mehrabi2
1 Department of Surgery, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
2 Department of General, Visceral and Transplantation Surgery, University of Heidelberg, 69120 Heidelberg, Germany
Correspondence should be addressed to Arianeb Mehrabi, arianeb
Received 23 March 2009; Accepted 25 May 2009
Recommended by Gianfranco D. Alpini
Common bile duct stones (CBDSs) may occur in up to 3%–14.7% of all patients for whom cholecystectomy is preformed. Patients
presenting with CBDS have symptoms including: biliary colic, jaundice, cholangitis, pancreatitis or may be asymptomatic . It is
important to distinguish between primary and secondary stones, because the treatment approach varies. Stones found before,
during, and after cholecystectomy had also differing treatments. Different methods have been used for the treatment of CBDS but
the suitable therapy depends on conditions such as patient’ satisfaction, number and size of stones, and the surgeons experience in
laparoscopy. Endoscopic retrograde cholangiopancreatography with or without endoscopic biliary sphincterotomy, laparoscopic
CBD exploration (transcystic or transcholedochal), or laparotomy with CBD exploration (by T-tube, C-tube insertion, or primary
closure) are the most commonly used methods managing CBDS. We will review the pathophysiology of CBDS, diagnosis, and
different techniques of treatment with especial focus on the various surgical modalities.
Copyright © 2009 Abolfazl Shojaiefard et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. Introduction
CBDSs are one of the medical conditions leading to surgical
intervention. They may occur in 3%–14.7% of all patients
for whom cholecystectomies are preformed [1, 2]. When
patients present with CBD, the one important question
that should be answered: what is the best modality of
treatment under the giving conditions? There are competing
technologies and approaches for diagnosing CBDS with
regard to diagnostic performance characteristics, technical
success, safety, and cost effectiveness. Management of CBDS
usually requires two separate teams: the gastroenterologist
and the surgical team [3]. One of the main factors in
the management is initially the detection of CBDS, before,
during, or after cholecystectomy. The main options for
treatment are pre- or postoperative ERCP with endoscopic
biliary sphincterotomy (EST), laparoscopic or open surgical
bile duct clearance. There are other options for the treatment of CBDS such as electrohydraulic lithotripsy (EHL),
extracorporeal shockwave lithotripsy (ESWL), dissolving
solutions, and laser lithotripsy. It is unlikely that one option
will be appropriate for all clinical circumstances in all centers.
Variables such as disease status, patient demographics,
availability of endoscopic, radiological and surgical expertise,
and healthcare economics will all have significant influence
on practice [4].
2. Method
A Medline-based search on all published papers (English and
German) for CBDS diagnosis and treatment was performed.
The search terms used for the review included common
duct stones, clinical presentation of CBDS, diagnostic
approach of CBDS, MRCP, transabdominal ultrasonography,
intraoperative cholangiography, common duct exploration,
common bile duct exploration, laparoscopic common bile
duct stone endoscopic sphincterotomy, trans-cystic, and
ductal approach. This paper serves to delineate the current
relevant concepts in the varying treatments of patients that
present with CBDS. We also present a possible algorithm for
the treatment of CBDS (Figure 1).
2
Gastroenterology Research and Practice
Symptomatic choledocholithiasis
Bilirubin ≥ 30 μmol/l,
dilated CBD,
colic pain
Bilirubin < 30 μmol/l,
NL or dilated CBD,
elevated LFTs
Cholangitis
or
severe pancreatitis
ERCP/EST
or
LC with IOC
ERCP
Successful
Successful
Failure
LC
Failure
LC
LC + LCD
LC + TC-CBDE
PTC
LC + TC-CBDE
Failure
Failure
or
or
Post-Op ERCP
LCD
Post ERCP
OCBDE
with IOC
Figure 1: Algorithm for management of common bile duct stones. LC: Laparoscopic cholecystectomy, LCD: Laparoscopic choledochotomy,
PTC: Percutaneous transhepatic catheter drainage, TC-CBDE: Transcystic common bile duct exploration, OCBDE: Open common bile duct
exploration, IOC: Intraoperative cholangiogram.
3. Pathogenesis and Clinical Manifestation
CBDS can be caused either by primary bile duct stones
that originate in the bile duct or by secondary bile duct
stones that have descended from the gallbladder [6]. In the
primary stones, bilirubin is dominant component and is
associated with biliary stasis and infection. In secondary
stones, cholesterol is dominant component. It is therefore
important to distinguish between primary and secondary
stones. Cholecystectomy and choledocholithotomy are sufficient in the management of secondary stones, while the
presence of primary stones often necessitates a more complex
drainage procedure to prevent recurrence [7, 8]. Table 1
shows the types of bile duct stones [5]. In addition,
cholecystectomy at a young age leads to CBD dilatation and
is another acquired risk factor for CBD stones [9].
The symptoms and signs of CBDS are highly variable
and can range from patients being completely asymptomatic,
to complications such as cholangitis or pancreatitis [10].
Literature describes the Prevalence of asymptomatic CBDS
between 5.2% and 12% [11]. A common presentation of
CBDS is the biliary colic. Pain is often situated in the
right hypochondrium or epigastrium and can last from 30
minutes to several hours, with associated symptoms such
as nausea and vomiting [10]. Other common symptoms
include pale stools and dark-colored urine, which can be
elicited in the patient history by a thorough review of systems
[12]. Two serious complications of CBDS are cholangitis and
gallstone pancreatitis. Acute obstructive cholangitis (AOC)
is a life-threatening complication caused by an infection of
the biliary ductal system secondary to biliary obstruction.
Cultures are most often positive for E. coli, and the infection
clears in more than 75% of cases with antibiotic treatment
[13]. In cholangitis, the classic symptoms of Charcot’s triad
may be encountered, and the less common Reynold’s pentad
adds to the diagnosis [7, 13]. Despite the advancement in
treatment, AOC still carries a mortality rate of 10–20% [14].
It remained unclear for a long time why some gallstone
patients suffer from pancreatitis, while others are spared
from this potentially lethal c (...truncated)